Brief: ISR FY 2022 Oper Loss Widens To SEK 205.1 Mln
March 1 (Reuters) - ISR Immune System Regulation Holding
AB (publ) ISR.ST :
* SAID IN TUESDAY JAN-DEC 2022 OPER LOSS SEK 205.1 MLN VS
LOSS SEK
78.6 MLN YR AGO
Source text for Eikon: urn:newsml:reuters.com:*:nWkr8FcDgr
Further company coverage: ISR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on ISR Immune System Regulation Holding AB (publ)
See all newsBrief: ISR Holding Shares To Be Delisted From Nasdaq First North Growth Market
Brief: Nasdaq Stockholm Hands Over Investigation Of ISR Holding To Disciplinary Committee
Brief: ISR Immune System Regulation Holding Receives Notice Of Objection From Nasdaq
Brief: ISR FY 2022 Oper Loss Widens To SEK 205.1 Mln
Brief: ISR Signs Development Agreements With Catalent